Dyne Therapeutics, Inc. (DYN)
19.52
+1.08
(+5.86%)
USD |
NASDAQ |
Dec 10, 12:16
Dyne Therapeutics EPS Diluted (Quarterly): -0.7619 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | -1.265 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -108.04M |
| Total Expenses (Quarterly) | 108.04M |
| Enterprise Value | 1.962B |
| Earnings Yield | -18.75% |
| Normalized Earnings Yield | -18.75 |